Jonathan P. Mow, Chief Executive Officer at PhaseBio Pharmaceuticals Inc (PHAS), bought 2,200 shares at $3.88 ($9K) on 2018-12-07, disclosed to the SEC on 2018-12-11.
Open-market purchase of $9k PHAS by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |